Spirax-Sarco Engineering plc

First-half organic revenue/sales grew 5%, adjusted operating profit grew 6% organically, adjusted operating margin was 19.8% (up 10 bps), and adjusted EPS rose 9% to 150p per share. By business, STS sales were up 1% and margin was 22% (down 170 bps); ETS sales were up 11% and margin was 17.2% (up 220 bps); Watson-Marlow sales were up 7% and margin was 27.5% (up 80 bps). Adjusted cash from operations was GBP 92 million, cash conversion was 54%, net debt was GBP 618 million, and net debt/EBITDA was 1.6x. The interim dividend was 50.4p per share, up 3%. For the full year, management expects cash conversion of around 90%, CapEx at the lower end of 4% to 5% of sales, negligible FX impact on revenue, and a 2% FX headwind on profit in the second half to offset the first-half tailwind. They reiterated full-year guidance and said STS margin should be higher in H2, ETS margin slightly ahead of H1, and Watson-Marlow margin broadly similar to H1.

Nimesh Patel emphasized that the company is increasingly able to grow ahead of weak industrial production because of its diversified end markets, direct sales model, and investments in commercial and digital capabilities. He said the Together for Growth strategy is strengthening the business model, helping self-generate demand, and supporting medium-term targets in STS, ETS, and Watson-Marlow. His tone was confident and constructive, repeatedly stressing that the company is not reliant on a cyclical IP recovery to deliver its numbers.

Louisa Burdett focused on the adjusted financials and said first-half results were in line with expectations. She highlighted 5% organic sales growth, 6% organic operating profit growth, 19.8% margin, and 150p EPS, plus GBP 92 million of operating cash flow, 54% cash conversion, GBP 618 million net debt, and 1.6x net debt/EBITDA. She said the lower first-half cash conversion reflected planned inventory builds tied to Middle East supply-chain risk, CapEx was around 3% of sales and is now expected at the low end of the 4% to 5% range, and leverage should return to the 1.0x to 1.5x target range by year-end. She also said future dividend growth should more closely track earnings growth now that dividend cover is back in target range.

Analysts pressed management on STS large orders, China, ETS margin targets, semicon durability, Watson-Marlow growth, and capital allocation. Management said STS demand was more than 2x IP, the H1 shipment timing headwind was in the low single-digit millions of pounds, and China could reach neutral growth earlier in the stated range of late this year or early next year. On ETS, management said the 20% margin target is still valid, that the business can exceed 20% over time, but future choices will balance higher margins against reinvestment for longer-term growth. On capital allocation, management said bolt-on M&A remains on the agenda, while buybacks could be considered if leverage falls to the bottom end of the 1.0x to 1.5x range and no attractive reinvestment opportunities are available.